Reimbursement Scheme Mounjaro KwikPen® for the indication Diabetes Mellitus type 2

The health insurer does not fully reimburse Mounjaro KwikPen for the indication Diabetes Mellitus type 2. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal Contribution to the patient.

Conditions

The Personal Contribution for Mounjaro KwikPen for the Indication Diabetes Mellitus type 2 that is demonstrably charged to the patient by the health insurer will be fully reimbursed from 11-11-2024 up to a maximum of € 250 per patient per year. 

There is no reimbursement for Personal Contributions for the indication Obesity.

The reimbursement for Mounjaro 2,5 mg dose is limited to one pack per patient.

Who can submit a claim

Only patients or their carer can claim the Personal Contribution for Mounjaro KwikPen online. Pharmacists cannot claim this medicine on behalf of the patient.

For more information check out the Mounjaro medicine page

_{PP-TR-NL-0163}